Middle East And Africa Polymyositis Market Size & Outlook, 2026-2034


Middle East And Africa Polymyositis Market Insights

  • As per Reed Intelligence insights, Middle East And Africa’s Polymyositis Market was valued at USD 153.61 Million in 2025 and is anticipated to expand to USD 279.05 Million by 2034.
  • From 2026 to 2034, the market is anticipated to expand at a CAGR of 6.81%.
  • Within Treatment Type, Corticosteroids accounted for the largest market size in 2025.
  • During the forecast period, Corticosteroids is anticipated to remain the highest-growth segment within the Treatment Type category.

Other Key Findings


  • Middle East And Africa represented 12% of the global Polymyositis Market size in 2025.
  • By 2034, United States is estimated to hold the largest position in the global market in terms of size.
  • Egypt is estimated to remain the fastest-growing market in Middle East and Africa, advancing to USD 30.22 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 153.61 Million
Market Size In 2034 USD 279.05 Million
Largest segment Corticosteroids
Units Revenue in USD Million
CAGR 6.81% (2026-2034)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
Treatment Type
  1. Corticosteroids
  2. Immunosuppressants
  3. Biologics
  4. Others
Diagnosis Method
  1. Blood Tests
  2. Imaging Techniques
  3. Muscle Biopsy
  4. Electromyography
End-Use
  1. Hospitals
  2. Specialty Clinics
  3. Research Institutes
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends